Healthcare organizations work with pharmacy data, EHRs, medical imaging, claims, clinical notes, laboratory data, and other real-world data (RWD). This data has to be transformed, standardized, or curated before it is used in AI development or regulatory research. The European Medicines Agency (EMA) provides frameworks for evaluating RWD quality, which uses healthcare databases across Europe to generate real-world evidence for regulatory decision-making.
This raises an important question: where can organizations obtain healthcare datasets from Europe suitable for AI development and regulatory applications?
Rather than relying on claims of EMA-compliant data, organizations should assess provenance, legal basis, governance, quality, representativeness, interoperability, security, and fitness for purpose.
This guide examines the need of the European Medicines Agency (EMA) and networks, the differences between EMA expectations and GDPR requirements, and how to analyze datasets for healthcare AI and regulatory use.
What Does “EMA-Compliant Medical Dataset” Actually Mean?
There is no universal EMA certification that makes a commercial medical dataset EMA-compliant. Instead, a dataset’s suitability for regulatory use relies on the specific research question, data quality, methodology, governance, study design, and regulatory context.
EMA’s Data Quality Framework for EU medicines regulation offers a structured approach to assessing data quality. The framework is intended to help stakeholders select and assess data sources for regulatory studies. Its real-world-data guidance uses a contextual approach rather than prescribing one fixed set of quality thresholds for every dataset.
If a data vendor claims to be EMA-ready, buyers must ask about:-
How was the data collected?
How is data quality measured?
What is the original source of the data?
How current is the data?
What population does it represent?
What variables are available?
How complete are those variables?
Is the data anonymized or pseudonymized?
What legal basis permits its use?
Is the source included in relevant HMA-EMA catalogs?
Can the data be used for AI model development?
Can it be used for regulatory research?
EMA vs GDPR vs EHDS: What Is the Difference?
EMA, GDPR, and EHDS serve different purposes in the European healthcare data ecosystem, covering regulatory evidence, data protection, and how health data can be accessed and reused for permitted purposes.
EMA
The EMA is concerned with medicines regulation and the quality and usefulness of evidence supporting regulatory decision-making. EMA’s Data Quality Framework provides principles for assessing the quality of data used in medicines regulation.
GDPR
GDPR governs the processing and protection of personal data in the EU/EEA. Health information is particularly sensitive and requires appropriate legal, technical, and organizational safeguards. Therefore, a dataset can be high quality from a clinical or regulatory perspective but still require appropriate GDPR governance.
EHDS
The European Health Data Space establishes an EU framework for accessing and sharing electronic health data and for the secondary use of health data for research, innovation, policy-making, and regulatory activities. The regulation entered into force in March 2025, with secondary-use provisions applying progressively from 2029.
EU AI Act
For AI developers, the regulatory picture can go beyond data protection and medicines regulation. Depending on the product and use case, AI Act obligations may also become relevant.
What Types of Medical Data Can AI Companies Source?
Medical data encompasses far more than traditional patient records. Depending on the AI application, organizations may source different data types. Each source provides different levels of clinical detail, population coverage, longitudinal information, and suitability for AI development or real-world evidence generation.
1. Electronic Health Records (EHRs)
EHRs provide longitudinal information collected during routine patient care. Depending on the healthcare system and data source, they may include diagnoses, procedures, medications, laboratory results, clinical encounters, demographic information, and clinical notes. As EHRs can capture patient journeys over time, they can support patient stratification, disease modeling, outcome prediction, clinical research, and healthcare AI applications. However, coding practices, data completeness, and documentation standards can vary across healthcare providers and countries, making data quality and standardization important considerations.
2. Claims and Administrative Data
Claims data primarily captures interactions among patients, healthcare providers, and payers. Depending on the source, it can contain information about diagnoses, procedures, healthcare utilization, prescriptions, reimbursement, hospitalizations, provider interactions, and healthcare costs.
Its major strength is broad population coverage and longitudinal information about healthcare utilization. However, claims data generally provides less clinical detail than EHRs and may not contain the granular information required for certain diagnostic or clinical AI applications.
3. Medical Imaging Data
Medical imaging datasets may include CT, MRI, X-ray, ultrasound, mammography, PET, pathology and whole-slide images, and ophthalmic imaging.
For medical AI, images alone may not be sufficient. Depending on the application, organizations may also require clinical reports, DICOM metadata, acquisition parameters, diagnostic labels, annotations, segmentation masks, and relevant patient or study context.
The quality and consistency of these supporting labels are particularly important when datasets are being developed for diagnostic, detection, segmentation, or clinical decision-support applications.
4. Clinical Notes and Other Unstructured Data
A significant amount of healthcare information exists as free text rather than structured database fields. This may include physician notes, discharge summaries, radiology and pathology reports, operative notes, and treatment plans.
Clinical NLP can extract structured information such as diagnoses, symptoms, medications, findings, procedures, and relationships between clinical entities from these documents. This makes raw clinical data valuable for research, information extraction, clinical decision support, and AI model development.
5. Registries and Disease-Specific Data
Patient and disease registries provide focused information about particular diseases, treatments, procedures, patient populations, medical devices, and clinical outcomes.
Because registries are often designed around a defined clinical or research purpose, they can provide more targeted information than broad healthcare datasets. They may therefore be useful when organizations need data for a specific disease area or research question.
6. Laboratory, Biomarker, and Molecular Data
Laboratory and biomarker datasets can include information from hematology, biochemistry, microbiology, blood tests, biomarkers, genetic information, and molecular measurements.
These data sources can complement EHRs and other clinical datasets by providing objective measurements of a patient’s physiological or biological state. Depending on the application, they can support disease prediction, patient stratification, treatment-response analysis, drug development, and precision medicine.
What Makes a Medical Dataset Suitable for AI?
Volume alone is not enough. Dataset volume is only one part of the equation. Healthcare AI datasets should be assessed across multiple dimensions, including clinical relevance, quality, representativeness, governance, and fitness for purpose.
Data Provenance
Organizations should understand where the data originated, who collected it, how it was transformed, and what processes were applied before delivery.
Data Completeness
Missing information can affect model development. For instance, a dataset may contain millions of patient records but have limited availability for a variable that is critical to the intended AI application.
Data Accuracy
The dataset should be assessed for errors, inconsistencies, implausible values, duplicate records, and other quality problems.
Representativeness
A representative dataset should reflect the population in which the AI product is expected to operate, including relevant variation in age, sex, geography, disease severity, care setting, demographic characteristics where lawfully and appropriately handled, and healthcare utilization patterns.
Temporal Coverage
Healthcare practices, diagnostic methods, coding systems, and treatment patterns change over time. A dataset should therefore have sufficient temporal coverage for the intended application.
Clinical Relevance
The data should contain clinically meaningful variables that directly support the intended AI task, such as diagnosis, prediction, detection, or treatment-response analysis.
How EMA Evaluates Real-World Data Quality
EMA’s current real-world-data quality framework does not simply ask whether a dataset is good or bad. It promotes a contextual assessment based on the intended use of the data. EMA describes three broad types of quality determinants:
Foundational – assesses basic data characteristics such as accessibility, availability, provenance, and governance.
Intrinsic – evaluates the inherent quality of data, including completeness, accuracy, validity, and consistency.
Question-specific – determines whether the data is fit for the intended research question, analysis, or regulatory use.
The framework is designed to support transparent evaluation of real-world data quality for regulatory purposes rather than imposing one universal threshold on every dataset. This is important for AI developers because a dataset that is appropriate for one application may not necessarily be appropriate for another. For instance, a large EHR dataset might be useful for population-level disease epidemiology but may not contain the imaging data or detailed clinical labels needed to train a diagnostic imaging model. Therefore, dataset suitability must be analyzed against the intended AI task.
Are GDPR-Compliant Datasets Automatically Suitable for EMA Use?
GDPR compliance does not automatically make a healthcare dataset suitable for EMA-related research or regulatory use. The two address different requirements. GDPR focuses on how personal data is gathered, processed, protected, and shared, while EMA-related use also depends on whether the data is relevant, reliable, complete, representative, and fit for the specific research or regulatory question.
Therefore, GDPR compliance alone does not establish:
Clinical validity
Data completeness and accuracy
Population representativeness
Fitness for the intended research question
Regulatory suitability
Adequate documentation and traceability
Appropriate study methodology
The same principle applies in reverse: data suitable for an EMA-related study is not automatically suitable for training a medical AI model. AI development may require additional attributes, such as high-quality labels, appropriate annotations, sufficient population diversity, and data that aligns with the model’s intended task. The key consideration is not simply whether the data is compliant, but whether it is fit for the specific purpose for which it will be used.
Medical Dataset Requirements for AI Model Training
If the purpose is AI development rather than real–world evidence alone, organizations should evaluate additional characteristics.
Ground-Truth QualityAre the clinical labels, diagnoses, or reference outcomes accurate and supported by appropriate clinical evidence?
Annotation ConsistencyAre labels applied consistently across annotators, clinicians, sites, and dataset batches?
Patient-Level DiversityDoes the dataset adequately represent the demographic, clinical, and disease characteristics of the population in which the AI system will be deployed?
Site DiversityDoes the dataset include data from multiple hospitals, imaging centers, healthcare systems, or geographic locations to reduce dependence on a single site?
Modality and Acquisition DiversityFor medical imaging, does the dataset capture variation across scanner manufacturers, models, imaging protocols, acquisition parameters, and clinical settings?
Metadata AvailabilityDoes the dataset retain relevant demographic, clinical, imaging, and acquisition metadata needed for analysis, while maintaining appropriate privacy protections?
Label ProvenanceCan the organization trace how each diagnosis, clinical label, or annotation was generated, reviewed, and validated?
Data Leakage and Patient OverlapHave duplicates, repeated examinations, related encounters, or the same patients been appropriately identified and separated across training, validation, and test sets to prevent artificially inflated model performance?
How Cogito Tech Can Support the Data-to-AI Pipeline
Cogito Tech helps healthcare organizations transform complex medical data into structured, AI-ready datasets through medical data annotation, clinical NLP, dataset curation, and quality assurance.
Cogito Tech supports annotation across multiple imaging modalities and specialties, including:
Medical Annotation
CT and MRI – Anatomical structures, lesions, tumors, organs, and other clinically relevant findings
X-ray and Ultrasound – Detection and localization of abnormalities and anatomical structures
Mammography – Lesion and abnormality annotation for breast imaging applications
Pathology – Annotation of tissue structures, cells, and pathological findings in whole-slide images
Ophthalmology – Annotation of retinal and other ophthalmic imaging data
Dental Imaging – Annotation of teeth, anatomical structures, and dental conditions
Clinical NLP and Text Annotation
Medical text can be transformed into structured information for healthcare AI and research applications through:
Clinical entity extraction
Medical named entity recognition (NER)
Relation extraction
Clinical document classification
Information extraction and structuring
De-identification workflows
These workflows can help convert unstructured clinical documents into datasets that are easier to analyze, search, and use for model development.
Medical Dataset Quality Assurance
High-quality medical AI requires more than accurate annotation. Cogito Tech’s QA workflows can include:
Annotation review and correction
Clinical expert validation
Inter-annotator agreement analysis
Consistency and completeness checks
Error analysis and resolution
Final dataset audits
By combining domain expertise, structured annotation workflows, and multi-stage quality assurance, organizations can build datasets that are more consistent, traceable, and aligned with the requirements of their intended healthcare AI applications.
Conclusion
European healthcare AI development requires a more sophisticated approach to medical data sourcing than simply finding a large dataset labeled GDPR compliant or EMA-compliant.
For medicines-related applications, EMA’s real-world-data quality framework provides important reference points for understanding data quality and regulatory evidence generation. For broader healthcare AI development, organizations must also consider GDPR, the developing EHDS framework, applicable AI and medical-device requirements, data licensing, clinical validity, and fitness for purpose.
Frequently Asked Questions
Are there EMA-certified medical datasets?+
EMA does not generally certify commercial medical datasets as “EMA-compliant.” Instead, EMA provides frameworks and guidance for assessing the quality and suitability of real-world data for medicines regulation. Dataset suitability depends on the research question, data quality, governance, study methodology, and regulatory context.
Is GDPR compliance enough for a medical AI dataset?+
Medical AI datasets need more than GDPR compliance. GDPR compliance addresses data protection and lawful processing. AI developers must additionally evaluate clinical relevance, data quality, representativeness, provenance, intended use, licensing, and applicable regulatory requirements.
Can medical datasets be used to train AI models?+
Potentially, but the permitted use depends on the dataset’s licensing, governance, legal basis, consent or other applicable legal mechanisms, and contractual restrictions. Organizations should confirm whether AI training and commercial use are explicitly permitted.
What medical data is best for AI?+
There is no universally best dataset. The appropriate data depends on the AI task, target population, clinical setting, geographic coverage, required labels, and regulatory purpose.
The post Medical Datasets in Europe: EMA, Quality, and Compliance for Healthcare AI appeared first on Cogitotech.